Butyrivibrio Crossotus Test

Butyrivibrio crossotus (B. crossotus) is a beneficial anaerobic bacterium that lives in the large intestine and specializes in fermenting complex dietary fibers. Its main metabolic product is butyrate, a short-chain fatty acid that serves as the primary fuel source for colonocytes, which are the cells lining the colon. This energy supply helps these cells maintain tight junctions, the protein structures that keep the gut barrier intact. A strong gut barrier limits the movement of lipopolysaccharides, or LPS, which are inflammatory molecules derived from gram-negative bacteria. When LPS enters the bloodstream, it can provoke low-grade systemic inflammation that contributes to metabolic dysfunction. By producing butyrate, B. crossotus indirectly helps prevent this inflammatory cascade.

Butyrate also influences immune activity within the gut. It promotes the development of regulatory T cells, or Tregs, a subset of immune cells that dampen inflammation and help maintain immune tolerance. This immune-modulating effect is one reason why higher levels of butyrate-producing bacteria are associated with reduced intestinal inflammation and better gut homeostasis. Beyond the gut, butyrate can signal through the gut-brain axis. This is the communication system linking the gut microbiota, the enteric nervous system embedded in the intestinal wall, and the central nervous system. Through this pathway, butyrate may influence neurological processes, which may help explain why lower B. crossotus abundance has been observed in certain neurological conditions such as dystonia.

Large cohort studies consistently show that B. crossotus is reduced in people with type 2 diabetes compared to individuals with normal glucose regulation. This pattern aligns with a broader theme: butyrate-producing bacteria tend to be depleted in insulin resistance. One of the reasons may involve branched-chain amino acids, or BCAAs, which are amino acids linked to metabolic disease when present at high circulating levels. B. crossotus plays a role in microbial pathways that help take up and metabolize BCAAs. Lower levels of this organism may therefore reduce the gut microbiome’s capacity to manage BCAAs, contributing to the metabolic disturbances seen in prediabetes and type 2 diabetes.

Diet strongly shapes the abundance of B. crossotus. High-fiber eating patterns, especially those rich in resistant starches and diverse plant polysaccharides, promote its growth. These fibers reach the colon undigested and serve as fermentable substrates for B. crossotus and other butyrate producers. Conversely, diets that trigger inflammation, including those high in saturated fats or low in fiber, are linked to lower levels of B. crossotus. Reduced levels have also been observed in individuals with chronic constipation, a condition that slows transit time and alters microbial fermentation patterns.

Altogether, B. crossotus serves as a marker of metabolic and gut health. Higher levels point toward a fiber-rich diet, a resilient gut barrier, and balanced immune activity, while lower levels are associated with insulin resistance, inflammation, and disturbances along the gut-brain axis.